Cabaletta Bio, Inc. (CABA) Reports In-Line Q1 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts CABA Hot Sheet
Join SI Premium – FREE
Cabaletta Bio, Inc. (NASDAQ: CABA) reported Q1 EPS of ($0.39), in-line with the analyst estimate of ($0.39).
For earnings history and earnings-related data on Cabaletta Bio, Inc. (CABA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AppLovin (APP) Tops Q3 EPS by 26c, Beats on Revenue; Offers Q4 Revenue Guidance
- Qualcomm (QCOM) Reports In-Line Q4 EPS, Beats on Revenue; Offers Q1 Guidance
- Centennial Resource Development, Inc. (PR) Tops Q3 EPS by 9c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
